Stakeholders Give FDA An Earful; Poor Communication, Recall Inefficiency, Patients At Risk
Executive Summary
During a recent listening session on modernizing its recall process, the US FDA heard from industry, consumers, and patients — all of whom expressed a common theme: the agency needs to up its game in how it handles recalls.